Today: 9 June 2026
Browse Category

NASDAQ:CRSP 22 June 2025 - 28 June 2025

June 2025 Science Breakthroughs and Projects: Medicine, Space, Climate, AI & More

June 2025 Science Breakthroughs and Projects: Medicine, Space, Climate, AI & More

Cancer cells siphon mitochondria from nerve cells through microscopic tubes, aiding metastasis, a Nature study found. Tumor DNA was detected in blood years before diagnosis, offering early screening potential. Casgevy, a CRISPR-based sickle-cell therapy, has treated over 90 patients since late 2024. NASA’s James Webb Space Telescope directly imaged exoplanet TWA-7b, a Saturn-mass gas giant.
Top 100 Global Biotechnology Companies Revolutionizing Science and Health

Top 100 Global Biotechnology Companies Revolutionizing Science and Health

Pfizer and BioNTech co-developed Comirnaty, the first FDA-approved mRNA COVID-19 vaccine. Roche leads in oncology and diagnostics, while Moderna advanced mRNA vaccines for COVID-19 and other diseases. Illumina dominates DNA sequencing, and CRISPR Therapeutics develops gene-editing therapies for sickle cell disease.

Stock Market Today

  • Analysis Suggests SpaceX IPO May Be Overvalued
    June 8, 2026, 6:56 PM EDT. Despite optimistic projections, SpaceX's initial public offering (IPO) could be overvalued. Evaluations indicate that only the most ambitious 'Moonshot' scenario nearly matches the proposed IPO price, raising concerns about high market expectations. Investors should weigh potential risks given the optimistic forecasts underpinning the valuation.

Latest articles

T1 Energy Shares Dip After KORE Power Files New Update

T1 Energy Shares Dip After KORE Power Files New Update

9 June 2026
T1 Energy shares slid 3.2% to $9.13 after a new SEC filing revealed up to $24.7 million in stock-linked payments for its $32 million KORE Power acquisition, spotlighting dilution risks as the company expands into battery storage and data-center power; the deal’s structure and timing come as T1 seeks growth funding and investors weigh near-term costs against future EBITDA targets.
OpenAI IPO filing puts AI rally at center stage for Wall Street

OpenAI IPO filing puts AI rally at center stage for Wall Street

9 June 2026
OpenAI has confidentially filed for a possible IPO, but investors won’t see key financials—including revenue quality, cash burn, and compute costs—until the S-1 goes public; with $2 billion monthly revenue and a recent $852 billion valuation, the filing signals a pivotal shift as AI giants race for public capital amid rising infrastructure costs and growing competition from Anthropic.
Wall Street Volatility Index Jumps as Chip Stocks Swing

Wall Street Volatility Index Jumps as Chip Stocks Swing

9 June 2026
The VIX plunged 12% to 18.92 as chip stocks rebounded sharply, with the Philadelphia Semiconductor Index jumping 5.6% and Intel soaring 11.2% after a major Google order, clawing back part of Friday’s $1.3 trillion rout; investors remain cautious ahead of key inflation data, interest rate decisions, and Middle East risks.
UBS Puts $850 Target on Cummins as AI Data Center Wave Fuels Shares

UBS Puts $850 Target on Cummins as AI Data Center Wave Fuels Shares

9 June 2026
UBS upgraded Cummins to Buy and hiked its price target to $850 from $565, citing surging data-center backup power demand and a stronger North American truck cycle; Cummins shares jumped 3.3% to $672.68 as UBS projected 2028 EPS of $41.25, topping consensus, and flagged double-digit Power business growth and raised long-term targets as key drivers.
Go toTop